Published in Immunobiology on July 20, 2006
Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol (2008) 2.19
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer (2012) 2.16
The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer (2010) 2.03
CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal (2012) 1.64
Revision joint replacement, wear particles, and macrophage polarization. Acta Biomater (2012) 1.21
Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol (2007) 1.12
The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC. PLoS One (2011) 1.01
The mononuclear phagocyte system in homeostasis and disease: a role for heme oxygenase-1. Antioxid Redox Signal (2014) 1.01
New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Clin Exp Immunol (2008) 1.01
Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch (2011) 1.00
Haptoglobin halts hemoglobin's havoc. J Clin Invest (2009) 0.96
The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging. Oxid Med Cell Longev (2013) 0.95
Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients. J Clin Immunol (2012) 0.89
Dendritic cells a double-edge sword in autoimmune responses. Front Immunol (2012) 0.87
CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation. BMC Immunol (2014) 0.78
Drug Trafficking into Macrophages via the Endocytotic Receptor CD163. Membranes (Basel) (2015) 0.78
Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer. Oncoimmunology (2015) 0.77
Association of steroid use with complicated sigmoid diverticulitis: potential role of activated CD68+/CD163+ macrophages. Langenbecks Arch Surg (2011) 0.77
Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis. J Gastroenterol (2014) 0.77
Bright expression of CD91 identifies highly activated human dendritic cells that can be expanded by defensins. Immunology (2015) 0.75
Elevated monocyte phosphorylated p38 in nearby employees after a chemical explosion. Sci Rep (2016) 0.75
Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. J Clin Oncol (2009) 1.84
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. Hepatology (2014) 1.73
The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis (2005) 1.60
Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood (2002) 1.58
Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS. Gut (2011) 1.52
HIV infection and arterial inflammation assessed by (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET): a prospective cross-sectional study. J Nucl Cardiol (2014) 1.46
Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood (2009) 1.41
Structure of the haptoglobin-haemoglobin complex. Nature (2012) 1.40
Haptoglobin-related protein is a high-affinity hemoglobin-binding plasma protein. Blood (2006) 1.31
Hemoglobin is a co-factor of human trypanosome lytic factor. PLoS Pathog (2007) 1.31
Hemoglobin and heme scavenger receptors. Antioxid Redox Signal (2010) 1.27
Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J Leukoc Biol (2010) 1.23
The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis. Pharmacol Rev (2011) 1.19
Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. Eur J Haematol (2004) 1.18
Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption. Antioxid Redox Signal (2012) 1.17
Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis Rheum (2004) 1.06
High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study. Crit Care (2007) 1.02
A pivotal role of the human kidney in catabolism of HDL protein components apolipoprotein A-I and A-IV but not of A-II. Lipids (2008) 1.00
Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. Int J Cancer (2012) 0.97
Novel STAT1 alleles in a patient with impaired resistance to mycobacteria. J Clin Immunol (2010) 0.96
A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. J Biol Chem (2006) 0.95
Efficient intracellular drug-targeting of macrophages using stealth liposomes directed to the hemoglobin scavenger receptor CD163. J Control Release (2012) 0.95
Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding. Immunobiology (2009) 0.93
Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression. Immunobiology (2011) 0.93
Haptoglobin: the hemoglobin detoxifier in plasma. Trends Biotechnol (2012) 0.91
Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis (2006) 0.90
Diagnostic value of soluble CD163 serum levels in patients suspected of meningitis: comparison with CRP and procalcitonin. Scand J Infect Dis (2007) 0.90
Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages. J Biol Chem (2013) 0.90
Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control study. BMC Infect Dis (2013) 0.89
Preterm delivery predicted by soluble CD163 and CRP in women with symptoms of preterm delivery. BJOG (2005) 0.88
Targeting dexamethasone to macrophages in a porcine endotoxemic model. Crit Care Med (2013) 0.88
CD163 binding to haptoglobin-hemoglobin complexes involves a dual-point electrostatic receptor-ligand pairing. J Biol Chem (2013) 0.86
Impaired CD163-mediated hemoglobin-scavenging and severe toxic symptoms in patients treated with gemtuzumab ozogamicin. Blood (2008) 0.85
Genotyping increases the yield of angiotensin-converting enzyme in sarcoidosis--a systematic review. Dan Med J (2014) 0.83
A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness. Clin Chem Lab Med (2014) 0.83
Glycemic control in diabetes in three Danish counties. Clin Chem Lab Med (2005) 0.83
Biological variation of anti-αGal-antibodies studied by a novel Time-Resolved ImmunoFluorometric Assay. J Immunol Methods (2011) 0.83
Trimerization of apolipoprotein A-I retards plasma clearance and preserves antiatherosclerotic properties. J Cardiovasc Pharmacol (2008) 0.83
Obesity and risk of infection: results from the Danish Blood Donor Study. Epidemiology (2015) 0.83
Soluble CD163 and interleukin-6 are increased in aqueous humour from patients with endothelial rejection of corneal grafts. Acta Ophthalmol Scand (2005) 0.82
Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival. Infect Dis (Lond) (2015) 0.79
Hepatic macrophage activation predicts clinical decompensation in chronic liver disease. Gut (2013) 0.78
Is hepatotoxicity in patients treated with gemtuzumabozogamicin due to specific targeting of hepatocytes? Leuk Res (2011) 0.78
Insulin-like growth factor I receptor density on CD4+T-lymphocytes from active early steroid- and DMARD-naïve rheumatoid arthritis patients is up-regulated and not influenced by 1 year of clinically effective treatment. Rheumatol Int (2011) 0.77
Reply: To PMID 24623375. Hepatology (2015) 0.75
[Noninvasive fetal RHD genotyping in a previously Rh-isoimmunized pregnant woman]. Ugeskr Laeger (2005) 0.75
[In Process Citation]. Ugeskr Laeger (2014) 0.75
[The iron hormone hepcidin: A future diagnostic marker and therapeutic target in the treatment of anemia and hemochromatosis?]. Ugeskr Laeger (2005) 0.75
[Dyslipoproteinemia--a risk factor of both arterial and venous thrombosis?]. Ugeskr Laeger (2006) 0.75
[Semiobjective and real pain in fibromyalgia]. Ugeskr Laeger (2002) 0.75